If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 81 - 90 of 305
PRecIsion in SCLC Via a Multicohort Study: Randomized Phase II Studies Evaluating Maintenance Durvalumab With or Without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer
Objective
A Phase II randomized study evaluating Durvalumab with or without personalized treatment for Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Protocol No
SWOG-S2409-PRISM
Categories
Multi-Arm Phase 2 Platform Study of Ubamatamab (REGN4018; MUC16×CD3 Bispecific Antibody) With or Without Additional Agents in Platinum-Resistant Ovarian Cancer
Objective
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Protocol No
REGENERON-R4018-ONC-2445
Categories
A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study
Objective
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Protocol No
NEURO-MAYO-APT
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
Objective
Comparing the Effectiveness of Less Invasive Procedures with the Current Standard of Care for Older Adults with Early-Stage Melanoma
Protocol No
ECOG-EA6244
Categories
An Open-Label Clinical Trial Investigating the Long-Term Safety of Buntanetap in Treating Participants with Parkinson's Disease
Objective
Long-Term Safety of Buntanetap in Parkinson's Disease
Protocol No
NEURO-ANNOVIS-ANVS-25002
A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants With Classic Congenital Adrenal Hyperplasia (Calm-CAH)
Objective
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Protocol No
ENDO-CRINETICS-CALM-CAH
Categories
Phase III Trial of Radiotherapy Followed by Adjuvant Temozolomide in Combination With the IDH Inhibitor Vorasidenib vs Placebo in IDH-Mutated Newly-Diagnosed Grade 3 Astrocytomas
Objective
Testing Add of Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Adv Brain Cancer
Protocol No
ALLIANCE-A072301
Categories
A Phase 3 Randomized, Double-Blind, Active-Controlled Study of Palazestrant With Ribociclib Versus Letrozole With Ribociclib for the First-Line Treatment of ER+, HER2- Advanced Breast Cancer
Objective
Palazestrant in Combo W/Ribociclib for the First-line Treatment of ER+/HER2- Advanced BC
Protocol No
OLEMA-OP-1250-302-OPERA
Categories
A Phase I Multicohort Trial of Zamtocabtagene Autoleucel (Zamto-Cel) in Subjects with Severe Refractory Autoimmune Diseases
Objective
US Zamto-cel Autoimmune Diseases
Protocol No
RHEU-MILTENYI-M-2024-423
Categories
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Single, Site, Pragmatic Pilot Study
Objective
Impact of Glucagon-like Peptide on Disease Outcomes
Protocol No
RHEU-IIT-SINGLA-GLP-1
Categories